[1]
J. Rodríguez Quintosa, C. C. Ago, A. Sicras Mainar, R. Villoro, and I. Pérez-Román, “Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain”, Grhta, vol. 9, no. 1, pp. 133–137, Oct. 2022.